CClinicalTrials.gg
RecruitingNCT07087405Updated May 28, 2026

Striae Distensae Treatment Using Deep Skin Abrasion

An interventional study of Striae Distensae Treatment Device in Striae Distensae, sponsored by Boston Children's Hospital. Recruiting at 1 site in United States. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-05-28.

Sponsored by Boston Children's Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Oct 2025; still recruiting 1 year later.
Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Not applicable
Ages
18 Years to 70 Years
Sex
All
01

Study summary

The goal of this clinical trial is to learn if a device works to treat striae distensae. It will also learn about the safety of the device. The main questions it aims to answer are:

  1. Does the device improve the appearance of striae distensae?
  2. Does the device cause any problems when treating striae distensae? Researchers will compare the appearance of striae distensae before and after treatment with the device.

Participants will:

  1. Undergo treatment with the device in the clinic
  2. Visit the clinic 1 week, 3 months, and 1 year for checkups and tests
Read the detailed description

Participants will have the area of striae distensae anesthetized with local anesthetic. A biopsy will be performed and a device will be placed underneath the skin that will abrade the skin. Three months later another biopsy will be performed, photographs will be taken, and participants will fill out surveys to determine the effectiveness of the device to improve the appearance of the striae distensae.

02

Conditions studied

  • Striae Distensae

Browse trials for

Keywords

  • Striae Distensae
03

In context

Striae Distensae

39 studies on the registry are indexed under Striae Distensae; 6 are open to participants now.

This study's planned enrollment of 10 is below the median of 28 across 38 interventional studies indexed under Striae Distensae.

Browse Striae Distensae studies →

Lead sponsor

Boston Children's Hospital is the lead sponsor of 598 studies on the registry; 151 are open to participants now.

Of its 31 completed or terminated interventional studies of FDA-regulated products, 18 (58%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Striae distensae

Exclusion criteria

Exclusion Criteria:

  • Smoking
  • coagulation deficiency
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (estimated)

Study arms

  • Experimental
    Striae Distensae Treatment

    Striae Distensae Treatment With A Device

    Device: Striae Distensae Treatment Device

Interventions

  • DeviceStriae Distensae Treatment Device

    One time deep skin treatment

06

What researchers measure

Primary outcomes

  1. Improvement in Striae Distensae Appearance

    Comparison of photographs before and after treatment

    Time frame: From enrollment to 12 months after treatment

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — IPD will be aggregated

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07087405
Lead sponsor
Boston Children's Hospital
Responsible party
Arin Greene (Professor of Surgery, Boston Children's Hospital) — Principal investigator
First posted
Jul 28, 2025
Start date
Oct 1, 2025
Primary completion
Dec 1, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
May 28, 2026

Study contacts

Arin Greene, MD
Contact
arin.greene@childrens.harvard.edu
16173552306
Patrick Smits, PhD
Contact
patrick.smits@childrens.harvard.edu
6173552306
Arin Greene, MD
principal investigator · Boston Children's Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion